Organ printing
Organ printing is a specific form of tissue engineering that follows a computer-aided, layer-by-layer deposition approach to create three-dimensional functional living organs. This process is driven by medical imaging data collected from the patient, which is then used to create a digital model of the organ to be printed.
History[edit]
The concept of organ printing was first proposed by Thomas Boland of Clemson University in 2003. The technology has since been developed and refined by numerous researchers and organizations worldwide, including the Wake Forest Institute for Regenerative Medicine and the University of Manchester.
Process[edit]
Organ printing involves three main steps: pre-printing, printing, and post-printing.
Pre-printing[edit]
The pre-printing phase involves the acquisition of medical imaging data, such as CT or MRI scans, from the patient. This data is then used to create a digital model of the organ to be printed.
Printing[edit]
The printing phase involves the layer-by-layer deposition of bio-ink, a material made up of living cells, to create the organ. This is typically done using a 3D printer.
Post-printing[edit]
The post-printing phase involves the maturation of the printed organ in a bioreactor, which provides the necessary conditions for the cells to grow and form a functional organ.
Applications[edit]
Organ printing has the potential to revolutionize organ transplantation by providing a solution to the shortage of donor organs. It could also eliminate the need for immunosuppressive drugs, as the printed organs would be made from the patient's own cells.
Challenges[edit]
Despite its potential, organ printing faces several challenges. These include the need for suitable bio-inks, the difficulty of creating complex organ structures, and the need for vascularization to supply the printed organ with nutrients.
See also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


